RELY filings show 10b5-1 sale of 9,000 and proposed 5,000-share sale
Rhea-AI Filing Summary
Remitly Global insider filing shows a proposed sale of 5,000 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $97,000. The shares were acquired as restricted stock units on 02/25/2024 and the filer lists an approximate sale date of 08/13/2025. The issuer's shares outstanding are shown as 206,193,217. The filing also discloses a prior Rule 10b5-1 sale by the same person on 05/14/2025 of 9,000 shares for $207,631.30. The filer affirms they do not possess undisclosed material adverse information and references Rule 10b5-1 trading plan conditions.
Positive
- None.
Negative
- None.
Insights
TL;DR Insider intends a small sale; size is minimal relative to outstanding shares and unlikely to move valuation.
The Form 144 shows a proposed sale of 5,000 shares (~$97,000) against 206,193,217 shares outstanding, indicating the transaction is very small on a company-wide basis. The shares were granted as restricted stock units on 02/25/2024, which is a routine form of executive compensation. The filing also notes a recent Rule 10b5-1 sale of 9,000 shares on 05/14/2025, suggesting planned selling rather than an ad hoc divestiture. From a market-impact perspective, these volumes are immaterial to total share count; the filing provides transparency but no new financial metrics.
TL;DR Disclosure follows Rule 144 conventions; use of broker and prior 10b5-1 sale indicate structured compliance with trading rules.
The notice names Morgan Stanley Smith Barney as the executing broker and documents the acquisition method (Restricted Stock Units) and dates, meeting standard disclosure expectations. The filer includes the usual representation that they do not possess undisclosed material information and references Rule 10b5-1 plan conditions where applicable. This filing is a routine insider disclosure that supports governance transparency but does not on its face raise material governance or compliance concerns.